Three decades of advancing care for rare disease communities

For more than three decades, Pharming has turned scientific possibility into real progress for rare disease communities. With two approved therapies and an international commercial footprint, we have built a credible reputation advancing novel therapies, earning trust through consistent delivery, and staying grounded in the voices of the people who rely on us.  

Powered by a global team with deep expertise, we continue to advance meaningful rare disease care and expand what’s possible for the communities we serve.